Calculator Template: Difference between revisions

Jump to navigation Jump to search
Ssharfaei (talk | contribs)
No edit summary
Ssharfaei (talk | contribs)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} (insert your name here)
{{CMG}}; {{AE}} (insert your name here)


Line 25: Line 26:


==Interpretation==
==Interpretation==
* Score ≤1: low-risk (<1% mortality); no treatment or hospital admission is required.
* Score ≤ 1: low-risk (< 1% mortality); no treatment or hospital admission is required.
* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
* Score ≥4: high-risk (>5% mortality); treatment/hospitalization is warranted.
* Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.


==See also==
==See also==

Revision as of 21:55, 4 February 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)

Synonyms and keywords: (add synonyms and create redirects)

Overview

[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score]

[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)

[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.

[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] Calculator

Shown below is the calculator for [Name of the Score] (check all the boxes that apply):

(insert widget here) {{#widget:Widget_Name}}

Interpretation

  • Score ≤ 1: low-risk (< 1% mortality); no treatment or hospital admission is required.
  • Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
  • Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.

See also

  • (Relevant score 1)
  • (Relevant score 2)
  • (Relevant score 3)

References